Pediatrix Medical Group, Inc. (NYSE: MD)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0000893949
Market Cap 1.83 Bn
P/B 2.05
P/E 11.28
P/S 0.95
ROIC (Qtr) 10.73
Div Yield % 0.00
Rev 1y % (Qtr) -3.58
Total Debt (Qtr) 642.27 Mn
Debt/Equity (Qtr) 0.72

About

Pediatrix Medical Group, Inc., often referred to as Pediatrix, is a leading provider of physician services in the healthcare industry. The company operates a national network of affiliated physicians who provide clinical care in 37 states, with a focus on enhancing patient care through evidence-based medicine. Pediatrix's main business activities include hospital-based and office-based operations, providing a range of services such as neonatal care, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. These services...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 290M provides robust 0.45x coverage of total debt 642.27M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 340.06M provide 9.05x coverage of short-term debt 37.56M, demonstrating strong liquidity position and minimal refinancing risk.
  • Robust free cash flow of 273.39M exceeds capital expenditure of 16.61M by 16.46x, indicating strong organic growth funding capability.
  • Operating cash flow of 290M provides strong 18.78x coverage of stock compensation 15.44M, indicating sustainable incentive practices.
  • Short-term investments of 123.04M provide solid 44.76x coverage of other current liabilities 2.75M, indicating strong liquidity.

Bear case

  • Operating cash flow of 290M barely covers its investment activities of (9.95M), with a coverage ratio of -29.14, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Free cash flow of 273.39M represents just -14.11x of debt issuance (19.38M), suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Retained earnings of (116.83M) provide limited buffer against comprehensive income items of 446000, which is -261.96x, indicating elevated exposure to market risks.
  • Operating cash flow of 290M is outpaced by equity issuance of (20.02M) (-14.49 ratio), indicating concerning reliance on equity markets for funding operations.
  • R&D investment of 0 represents just 0x of SG&A expenses of 238.66M, indicating potential underinvestment in innovation relative to administrative overhead.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.01 1.26
EV to Cash from Ops. EV/CFO 7.69 12.78
EV to Debt EV to Debt 3.47 12.10
EV to EBIT EV/EBIT 9.25 10.74
EV to EBITDA EV/EBITDA 10.08 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 8.15 18.02
EV to Market Cap EV to Market Cap 1.24 432.64
EV to Revenue EV/Rev 1.16 2.77
Price to Book Value [P/B] P/B 2.03 -1.92
Price to Earnings [P/E] P/E 11.12 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 6.53 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 39.87 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 227.51 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 188.80 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 226.99 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 203.74 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 174.64 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 162.87 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 137.34 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 16.22 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.87 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.87 0.39
Current Ratio Curr Ratio (Qtr) 1.83 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.72 -13.19
Interest Cover Ratio Int Coverage (Qtr) 6.53 -97.94
Times Interest Earned Times Interest Earned (Qtr) 6.53 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 13.70 -95.81
EBIT Margin % EBIT Margin % (Qtr) 12.54 -94.97
EBT Margin % EBT Margin % (Qtr) 10.62 -105.60
Gross Margin % Gross Margin % (Qtr) 25.80 23.31
Net Profit Margin % Net Margin % (Qtr) 8.40 -106.14